N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 06 Biological Sciences 0601 Biochemistry and Cell Biology

Krzysztof Marek Mrozik, Orest William Blaschuk, Chee Man Cheong, Andrew Zannettino, Kate Vandyke

Research output: Contribution to journalReview articlepeer-review

112 Citations (Scopus)


In many types of solid tumours, the aberrant expression of the cell adhesion molecule N-cadherin is a hallmark of epithelial-to-mesenchymal transition, resulting in the acquisition of an aggressive tumour phenotype. This transition endows tumour cells with the capacity to escape from the confines of the primary tumour and metastasise to secondary sites. In this review, we will discuss how N-cadherin actively promotes the metastatic behaviour of tumour cells, including its involvement in critical signalling pathways which mediate these events. In addition, we will explore the emerging role of N-cadherin in haematological malignancies, including bone marrow homing and microenvironmental protection to anti-cancer agents. Finally, we will discuss the evidence that N-cadherin may be a viable therapeutic target to inhibit cancer metastasis and increase tumour cell sensitivity to existing anti-cancer therapies.

Original languageEnglish
Article number939
JournalBMC cancer
Issue number1
Publication statusPublished or Issued - 1 Oct 2018


  • Cancer
  • Haematological malignancies
  • Metastasis
  • N-cadherin
  • Therapeutic target

ASJC Scopus subject areas

  • Oncology
  • Genetics
  • Cancer Research

Cite this